Collin Zimmer
Papers
2
Total Citations
53
H-Index
2
About
Collin Zimmer is a bioanalytical chemist whose work has advanced the precise quantification of pharmaceutical compounds in human plasma, with a particular focus on cardiovascular drugs. His research centers on the development and validation of highly sensitive liquid chromatography–tandem mass spectrometry (LC-MS/MS) methods, enabling accurate simultaneous measurement of parent drugs and their active metabolites. Zimmer’s most cited study, “Simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromatography–tandem mass spectrometry” (1998, 43 citations), provided a robust analytical tool for monitoring the calcium channel blocker nifedipine and its primary metabolite, a critical step for pharmacokinetic studies and therapeutic drug monitoring. He further contributed to the field with a method for quantifying molsidomine and its active metabolite (1998, 10 citations), supporting research into this vasodilator used for angina. Though his citation counts reflect a niche but impactful specialty, Zimmer’s work exemplifies the foundational analytical chemistry that underpins modern drug development and personalized medicine, offering reliable techniques that have been adopted by other researchers for similar bioanalytical challenges.
Research Focus
Key Achievements
Top Papers
- 1
- 2